Le Lézard
Classified in: Health, Business
Subject: CON

Quantum Health and City of Hope Collaborate to Provide State-of-the-Art Cancer Support Services


COLUMBUS, Ohio and DUARTE, Calif., March 6, 2018 /PRNewswire/ -- Quantum Health, Inc., the market leader in consumer navigation and care coordination, and City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, today announced a new collaboration to provide a range of enhanced cancer support services to clients of Quantum Health, their members and their physicians.

The complexity of cancer diagnosis and treatment has increased costs to employers. This personal cancer management program couples City of Hope's expertise in genomic medicine, commonly referred to as precision medicine, with Quantum Health's empathetic care support and navigation to provide a high level of customized service. City of Hope will specifically provide guidance on how to appropriately use genomic testing and to optimally integrate the results into a patient's care plan.

"City of Hope is at the forefront of precision medicine and cancer treatment expertise," stated Kara Trott, founder and CEO of Quantum Health. "Cancer is emotionally taxing for people and their families. The rapid pace of change leaves people bewildered about what to do. There is also a risk of misdiagnosis leading to unnecessary and nonbeneficial treatments that result in avoidable cost and suffering for the patient, as well as poorer outcomes. This relationship with City of Hope will arm our clinical care coordinators with information regarding the latest research and technology to deliver unparalleled cancer care navigation and support to our members, their families and their providers on their unchosen healthcare journey."

A cancer diagnosis directly affects only 1 percent of members on employer health plans, but is one of the costliest conditions, representing up to 10 to 12 percent of employers' medical costs.1 Precision medicine ? based on individuals' specific genetic and molecular make-up ? is changing the course of effectiveness in cancer treatments at an unprecedented pace, and can have a significant impact on the direct and indirect costs associated with a cancer diagnosis.

"We are excited to provide an unprecedented level of service and support for the benefit of Quantum Health's members by leveraging City of Hope's clinical expertise," said Harlan Levine, M.D., president of strategy and business ventures, at City of Hope. "Quantum Health's model uniquely enables early interception and support for patients undergoing cancer diagnosis and treatment, allowing us to provide the patient's clinical team paramount care and guidance."

About Quantum Health  
Quantum Health is an award-winning consumer healthcare navigation company that delivers an unparalleled consumer experience based on empathy and trust, enabling employers to achieve industry-leading satisfaction rates and independently validated claim savings. Launched in 1999, Quantum Health's model is based on years of consumer research and the insights learned from guiding millions of consumers and their providers through their healthcare journey. Based in Columbus, Ohio, Quantum Health has earned numerous awards and honors, including being named Entrepreneur of the Year by Ernst and Young, Fastest-Growing Privately Held Company for the past 10 years by Inc. 5000; one of the 50 Fastest-Growing Women-Owned/Led Companies for the past four years by the Women Presidents' Organization; a Best Place to Work for the past 10 years by Columbus Business First; and a Great Place to Work® Best Small & Medium Workplaces by FORTUNE Magazine and Entrepreneur Magazine. Learn more at Quantum-Health.com, and connect with us Facebook, Twitter, LinkedIn, and Instagram.

About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as one of only 49 comprehensive cancer centers, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the world. City of Hope is located in Duarte, California, just northeast of Los Angeles, with community practice sites throughout Southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation, diabetes and numerous breakthrough cancer drugs based on technology developed at the institution.

For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.

Media Contacts:                    
Becky Sparhawk 
P: 614-846-4318 ext. 1614 
[email protected]

Letisia Marquez 
P: 626-218-3398  
[email protected]

1 Millman, Cost Drivers of Cancer Care, 2016.

 

SOURCE Quantum Health, Inc.


These press releases may also interest you

at 21:00
OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, today published a report titled 'Unlocking the Infinite Potential of Crypto and AI.' The report explores the convergence of AI and crypto, a major trend in...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:45
The "Austria Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs on Social Commerce Trends by End-Use Sectors, Operational KPIs, Retail Product Dynamics, and Consumer Demographics - Q1 2024 Update" report has been added...

at 20:40
Osisko Development Corp. ("Osisko Development" or the "Company") reports its financial and operating results for the three and twelve months ended December 31, 2023 ("Q4 2023"). Q4 2023 HIGHLIGHTS Operating, Financial and Corporate Updates: 2,090...

at 20:39
TSX VENTURE COMPANIES BULLETIN V2024-0926 VALLEYVIEW RESOURCES LTD. ("VVR")BULLETIN TYPE:  Resume TradingBULLETIN DATE: March 28, 2024TSX Venture Tier 2 Company Reference is made to our bulletin dated March 26, 2024 with respect to the listing of the...

at 20:30
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Sonder Holdings Inc. resulting from allegations that Sonder may have issued materially misleading business...



News published on and distributed by: